Related references
Note: Only part of the references are listed.Risk of Major Amputation Following Application of Paclitaxel Coated Balloons in the Lower Limb Arteries: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Konstantinos Katsanos et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2022)
Safety of paclitaxel-coated devices in peripheral artery disease
Mary M. McDermott et al.
NATURE REVIEWS CARDIOLOGY (2021)
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
Michael D. Dake et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
Eva Freisinger et al.
EUROPEAN HEART JOURNAL (2020)
Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative
Daniel J. Bertges et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
Sabine Steiner et al.
EUROPEAN HEART JOURNAL (2020)
Paclitaxel-coated peripheral artery devices are not associated with increased mortality
Norman H. Kumins et al.
JOURNAL OF VASCULAR SURGERY (2020)
Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World
Tanja Boehme et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
Eva Freisinger et al.
EUROPEAN HEART JOURNAL (2020)
Mortality Not Correlated With Paclitaxel Exposure An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon
Peter A. Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices
Eric A. Secemsky et al.
JAMA CARDIOLOGY (2019)
Paclitaxel-Coated Balloons and Eluting Stents: Is There a Mortality Risk in Patients With Peripheral Artery Disease?
Joshua A. Beckman et al.
CIRCULATION (2019)
Vascular surgery trends in Australia: 2001-2015: less open surgery, less limb loss and more endovascular intervention
Melissa Anne Wright et al.
ANZ JOURNAL OF SURGERY (2019)
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
Frederick Zhang et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2019)
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment
Sabine Steiner et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2018)
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
William A. Gray et al.
LANCET (2018)
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Konstantinos Katsanos et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Drug-eluting balloon: design, technology and clinical aspects
Meenasree Bukka et al.
BIOMEDICAL MATERIALS (2018)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Marie D. Gerhard-Herman et al.
CIRCULATION (2017)
Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment
Yvonne Bausback et al.
JOURNAL OF ENDOVASCULAR THERAPY (2017)
In-stent restenosis management: the best is yet to come
Jos C. van den Berg
JOURNAL OF CARDIOVASCULAR SURGERY (2017)
Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
Henrik Schroeder et al.
CIRCULATION (2017)
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery 1-Year Results of the PACUBA Trial
Christian M. Kinstner et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Acotec Drug-Coated Balloon Catheter Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial
Xin Jia et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery
Akshaar Brahmbhatt et al.
TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Angioplasty of Femoral-Popliteal Arteries With Drug-Coated Balloons 5-Year Follow-Up of the THUNDER Trial
Gunnar Tepe et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Michael R. Jaff et al.
JOURNAL OF ENDOVASCULAR THERAPY (2015)
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Kenneth Rosenfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013
Youn Young Park et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2015)
Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease 12-Month Results From the IN. PACT SFA Randomized Trial
Gunnar Tepe et al.
CIRCULATION (2015)
The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization First-in-Human Randomized Trial of Low-Dose Drug-Coated Balloon Versus Uncoated Balloon Angioplasty
Dierk Scheinert et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery The DEBATE-SFA Randomized Trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery)
Francesco Liistro et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions
Johannes Lammer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions
Marc Bosiers et al.
JOURNAL OF VASCULAR SURGERY (2011)
Patterns of treatment for peripheral arterial disease in the United States: 1996-2005
Vincent L. Rowe et al.
JOURNAL OF VASCULAR SURGERY (2009)
The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings
J. Rits et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2008)
Share Paper
